Skip to content
10-K

Annual Report

FluoroPharma Medical, Inc.

0001654954-17-002914

← back to feed
Filed
Mar 31, 2017 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2016 · Mar 28, 2017 34.26M sh
Capex FY 2016 · Dec 31, 2016 $1.29K
Capex FY 2016 · Dec 31, 2015 $6.69K
Operating Cash Flow FY 2016 · Dec 31, 2016 −$880.12K
Operating Cash Flow FY 2016 · Dec 31, 2015 −$2.68M
Cash And Equivalents FY 2016 · Dec 31, 2016 $24.72K
Cash And Equivalents FY 2016 · Dec 31, 2015 $290.85K
Cash And Equivalents FY 2016 · Dec 31, 2014 $252.15K
Stockholders Equity FY 2016 · Dec 31, 2016 −$10.18M
Stockholders Equity FY 2016 · Dec 31, 2015 −$7.86M
Stockholders Equity FY 2016 · Dec 31, 2014 −$4.8M
Current Liabilities FY 2016 · Dec 31, 2016 $10.51M
Current Liabilities restated FY 2016 · Dec 31, 2015 $8.7M
Current Assets FY 2016 · Dec 31, 2016 $47.78K
Current Assets restated FY 2016 · Dec 31, 2015 $509K
Total Assets FY 2016 · Dec 31, 2016 $334.76K
Total Assets restated FY 2016 · Dec 31, 2015 $838.6K
Eps Basic FY 2016 · Dec 31, 2016 −$0.07
Eps Basic FY 2016 · Dec 31, 2015 −$0.12
Sga Expense FY 2016 · Dec 31, 2016 $1.69M
Sga Expense FY 2016 · Dec 31, 2015 $2.47M
Rd Expense FY 2016 · Dec 31, 2016 $511.38K
Rd Expense FY 2016 · Dec 31, 2015 $720.86K
Net Income FY 2016 · Dec 31, 2016 −$2.05M
Net Income FY 2016 · Dec 31, 2015 −$3.16M
Operating Income FY 2016 · Dec 31, 2016 −$2.2M
Operating Income FY 2016 · Dec 31, 2015 −$3.19M